Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding international clinical trial requirements and adapting to the rise of AI ...

There’s never been a more critical time for life sciences organizations to adopt strategies that help them strike a balance between mitigating risk and fueling innovation. AI has created a plethora of ...

The role of the life sciences industry in corporate social responsibility The life sciences industry consistently demonstrates leadership in corporate social responsibility through various stewardship ...

In Pharma and Life Sciences, compliance underpins every link in the global supply chain. Organizations must manage complex partner networks, navigate evolving regulations, and mitigate risk across ...

LONDON, June 27, 2024 (GLOBE NEWSWIRE) -- 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the greatest negative impact on the ...